Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

ACEP Clinical Policy on Emergency Department Management of Patients Needing Reperfusion Therapy for Acute ST-Segment Elevation Myocardial Infarction

By Susan B. Promes, MD, MBA, FACEP | on November 28, 2017 | 0 Comment
Uncategorized
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

Critical Questions

You Might Also Like
  • ACEP15 Session: Latest Recommendations for Non-ST Segment Elevation Myocardial Infarction, Unstable Angina
  • ACEP Clinical Policy on Acute Carbon Monoxide Poisoning
  • ACEP Clinical Policy Review: Evaluation and Management of Adult Patients in the ED with Asymptomatic Elevated BP
Explore This Issue
ACEP Now: Vol 36 – No 12 – December 2017
  1. In adult patients having a STEMI, are there patients for whom treatment with fibrinolytic therapy decreases the incidence of major adverse cardiac events (MACE) when PCI is delayed?

Patient Management Recommendations

  • Level A recommendations: None specified.
  • Level B recommendations: Fibrinolytics may be administered to patients when door-to-balloon (D2B) time is anticipated to exceed 120 minutes.
  • Level C recommendations: A dose reduction should be considered when administering fibrinolytics to patients age 75 years or older.
  1. In adult patients having a STEMI, does transfer to a PCI center decrease the incidence of MACE?

Patient Management Recommendations

  • Level A recommendations: None specified.
  • Level B recommendations: To decrease the incidence of MACE, patients with STEMI should be transferred to a PCI-capable hospital as soon as possible.
  • Level C recommendations: None specified.
  1. In adult patients undergoing reperfusion therapy, should opioids be avoided to prevent adverse outcomes?

Patient Management Recommendations

  • Level A recommendations: None specified.
  • Level B recommendations: None specified.
  • Level C recommendations: Because safety has not been established, clinical judgment should be used in deciding whether to provide or withhold morphine in patients undergoing reperfusion therapy.

Management of patients with acute STEMI in the emergency department can be challenging when PCI is not immediately available at the hospital where the patient initially presents. The administration of fibrinolytics to decrease the incidence of MACE should be considered when there is an anticipated prolonged delay from the time of initial presentation to PCI. Another topic discussed in this policy is the use of morphine in STEMI patients. Based on the committee’s review, the risk of prescribing morphine in patients suffering from an acute STEMI is unclear at this time.

Reference

  1. American College of Emergency Physicians Clinical Policies Subcommittee (Writing Committee) on Reperfusion Therapy for Acute ST-Segment Elevation Myocardial Infarction, Promes SB, Glauser JM, et al. Clinical policy: emergency department management of patients needing reperfusion therapy for acute ST-segment elevation myocardial infarction. Ann Emerg Med. 2017;70(5):724-739.

Dr. Promes is professor and chair of the department of emergency medicine at Penn State Health Milton S. Hershey Medical Center in Hershey, Pennsylvania.

Pages: 1 2 | Single Page

Topics: Clinical Guideline

Related

  • ACEP Clinical Policies Committee reviews Gastroenterology Guideline Update

    July 8, 2022 - 0 Comment
  • The Surviving Sepsis Campaign Creates COVID-19 Guideline

    November 23, 2021 - 0 Comment
  • New Guidelines Aim to Help the Evaluation of Chest Pain

    September 15, 2021 - 0 Comment

Current Issue

ACEP Now May 03

Read More

No Responses to “ACEP Clinical Policy on Emergency Department Management of Patients Needing Reperfusion Therapy for Acute ST-Segment Elevation Myocardial Infarction”

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*

Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603